XNCR
4:01 PM
Xencor to Present at the 2026 Cantor Global Healthcare Conference
PASADENA, Calif. --(BUSINESS WIRE)--Sep. 2, 2026-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that company management will present at the Cantor Global Healthcare
xencor.com